首页 › 基金 › NWI MANAGEMENT LP › BLTE
NWI MANAGEMENT LP 对 BLTE 的持仓历史
BELITE BIO INC · 医疗保健
NWI MANAGEMENT LP 在 Q3 2026 的 13F 申报中披露持有 BLTE(BELITE BIO INC)45,000 股,市值约 US$7.6M,约占其申报组合的 0.34%,在其申报持仓中市值排名第 40 位。 NWI MANAGEMENT LP 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
NWI MANAGEMENT LP 对 BLTE 的持仓演变
NWI MANAGEMENT LP 于 Q3 2026 首次披露 BLTE 持仓:45,000 股(约 US$7.6M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 45.00K | $7.64M | 新进 |
关于 BLTE 与 13F 数据
BLTE(BELITE BIO INC)属于医疗保健行业。我们追踪的基金中还有 73 只申报持有 BLTE,申报仓位最大的包括:Darwin Global Management, Ltd. (US$456.6M), Paradigm Biocapital Advisors LP (US$189.8M), RTW INVESTMENTS, LP (US$110.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 BLTE 的基金
- Darwin Global Management, Ltd. 3.08M 股 · $456.59M · Q2 2026
- Paradigm Biocapital Advisors LP 1.23M 股 · $189.84M · Q2 2026
- RTW INVESTMENTS, LP 715.33K 股 · $110.15M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 390.83K 股 · $66.37M · Q3 2026
- Maverick 资本 396.31K 股 · $61.03M · Q2 2026
- MAVERICK CAPITAL LTD 396.31K 股 · $61.03M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 357.20K 股 · $55.00M · Q2 2026
- Affinity Asset Advisors, LLC 242.09K 股 · $41.11M · Q3 2026
- Logos Global Management LP 250.00K 股 · $38.50M · Q2 2026
- Patient Square Capital LP 131.70K 股 · $22.37M · Q3 2026
- MPM BioImpact LLC 137.21K 股 · $21.13M · Q2 2026
- Artia Global Partners LP 24.99K 股 · $3.85M · Q2 2026
更多关于 NWI MANAGEMENT LP
常见问题
How long has NWI MANAGEMENT LP held BLTE?
NWI MANAGEMENT LP has disclosed BLTE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is NWI MANAGEMENT LP's current position in BLTE?
As of Q3 2026, NWI MANAGEMENT LP holds 45.00K shares of BLTE (BELITE BIO INC), valued at $7.64M, representing 0.34% of its reported portfolio and ranking #40.
Has NWI MANAGEMENT LP been buying or selling BLTE?
In the latest 13F filing (Q3 2026), NWI MANAGEMENT LP newly opened its position in BLTE.
Which other funds hold BLTE?
Other major institutional holders of BLTE include Darwin Global Management, Ltd., Paradigm Biocapital Advisors LP, RTW INVESTMENTS, LP, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.